These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 15482692

  • 1. [Necrotic lesion in a patient with hepatitis C virus liver disease under treatment with pegylated interferon].
    Rosel L, Blanco JR, Metota L, Oteo JA.
    Enferm Infecc Microbiol Clin; 2004 Oct; 22(8):497-8. PubMed ID: 15482692
    [No Abstract] [Full Text] [Related]

  • 2. [Cutaneous necrosis due to injection of interferon-alpha 2b in a patient with chronic hepatitis C].
    Castellanos González M, Pérez Carreras M, Muñoz Gómez R, Castellano Tortajada G.
    Gastroenterol Hepatol; 2011 Oct; 34(8):584-5. PubMed ID: 21641684
    [No Abstract] [Full Text] [Related]

  • 3.  Pegylated interferon, but not conventional interferon therapy induced severe skin lesions.
    Li Z, Ji F, Zheng Y, An J, Peng Z.
    Ann Hepatol; 2012 Oct; 11(4):570-1. PubMed ID: 22700642
    [No Abstract] [Full Text] [Related]

  • 4. Adverse skin reactions due to pegylated interferon alpha 2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus.
    Hashimoto Y, Kanto H, Itoh M.
    J Dermatol; 2007 Aug; 34(8):577-82. PubMed ID: 17683392
    [Abstract] [Full Text] [Related]

  • 5. Adverse cutaneous reactions to interferon alfa-2b plus ribavirin therapy in patients with chronic hepatitis C virus.
    Manjón-Haces JA, Vázquez-López F, Gómez-Díez S, Hidalgo-García A, Pérez-Alvarez R, Soler-Sánchez T, Pérez-Oliva N.
    Acta Derm Venereol; 2001 Aug; 81(3):223. PubMed ID: 11558891
    [No Abstract] [Full Text] [Related]

  • 6. [Exceptional pancytopenia secondary to treatment with pegylated interferon and ribavirin].
    Wikman Jorgensen PE, Jover Díaz FM, Cuadrado Pastor JM.
    Gastroenterol Hepatol; 2007 Apr; 30(4):253. PubMed ID: 17408558
    [No Abstract] [Full Text] [Related]

  • 7. [Patient with HCV chronic hepatitis who has subcutaneous nodules after finishing treatment with pegylated interferon].
    Salgado Ordóñez F, Manteca González R, Palacios Rodríguez S, Godoy Guerrero M.
    Rev Clin Esp; 2005 Dec; 205(12):621-2. PubMed ID: 16527184
    [No Abstract] [Full Text] [Related]

  • 8. [Diabetes mellitus during interferon therapy].
    Tarabini-Castellani P, Apraiz L, Portu J, Agud JM.
    Enferm Infecc Microbiol Clin; 2008 Feb; 26(2):120-1. PubMed ID: 18341927
    [No Abstract] [Full Text] [Related]

  • 9. Summaries for patients. Pegylated interferon with or without ribavirin for patients with hepatitis C receiving hemodialysis.
    Ann Intern Med; 2013 Dec 03; 159(11):I-14. PubMed ID: 24297207
    [No Abstract] [Full Text] [Related]

  • 10. Exacerbation of oral lichen planus lesions during treatment of chronic hepatitis C with pegylated interferon and ribavirin.
    Grossmann Sde M, Teixeira R, de Aguiar MC, do Carmo MA.
    Eur J Gastroenterol Hepatol; 2008 Jul 03; 20(7):702-6. PubMed ID: 18679075
    [Abstract] [Full Text] [Related]

  • 11. [Fatal Outcome for subcutaneous administration of Pegylated IFN alpha 2b in a man with Chronic C hepatitis under treatment with traditional bitherapy].
    Domínguez Gozalo A, Hidalgo Correas FJ, García Benayas E, García Díaz B.
    Farm Hosp; 2015 May 01; 39(3):186-8. PubMed ID: 26005896
    [No Abstract] [Full Text] [Related]

  • 12. [Pegylated-interferon alpha plus ribavirin-induced subacute thyroiditis in chronic hepatitis C].
    Abellán Galiana P, Pérez-Lázaro A, Aguilera Sancho-Tello V, Merino Torres JF, Berenguer Haym M, Piñón Sellés F.
    Endocrinol Nutr; 2009 Mar 01; 56(3):136-9. PubMed ID: 19627727
    [Abstract] [Full Text] [Related]

  • 13. Pyoderma gangrenosum and exacerbation of psoriasis resulting from pegylated interferon alpha and ribavirin treatment of chronic hepatitis C.
    Yurci A, Guven K, Torun E, Gursoy S, Baskol M, Akgun H, Ozbakir O, Yucesoy M.
    Eur J Gastroenterol Hepatol; 2007 Sep 01; 19(9):811-5. PubMed ID: 17700270
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pegylated interferon (alone or with ribavirin) for chronic hepatitis C in haemodialysis population.
    Espinosa M, Hernàndez J, Arenas MD, Carnicer F, Caramelo C, Fabrizi F.
    Kidney Blood Press Res; 2015 Sep 01; 40(3):258-65. PubMed ID: 25997572
    [Abstract] [Full Text] [Related]

  • 16. [Generalized eczema secondary to combined treatment with peginterferon alfa-2a and ribavirin in a patient with chronic hepatitis from the hepatitis C virus].
    Ruiz de Casas A, García-Bravo B, Camacho F.
    Actas Dermosifiliogr; 2005 Mar 01; 96(2):122-3. PubMed ID: 16476350
    [Abstract] [Full Text] [Related]

  • 17. [Early interruption of triple therapy with telaprevir in chronic hepatitis C due to severe adverse effects does not necessarily lead to treatment failure].
    Virolés Torrent S, López Nuñez C, Hombrados Verde M, Figa Francesch M, Ferri Iglesias MJ, Louvriex Freire R, Acero Fernández D.
    Gastroenterol Hepatol; 2015 Feb 01; 38(2):78-81. PubMed ID: 24948444
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation of the adverse effect of premature discontinuation of pegylated interferon α-2b and ribavirin treatment for chronic hepatitis C virus infection: results from Kyushu University Liver Disease Study.
    Ogawa E, Furusyo N, Kajiwara E, Takahashi K, Nomura H, Tanabe Y, Satoh T, Maruyama T, Nakamuta M, Kotoh K, Azuma K, Dohmen K, Shimoda S, Hayashi J, Kyushu University Liver Disease Study [KULDS] Group.
    J Gastroenterol Hepatol; 2012 Jul 01; 27(7):1233-40. PubMed ID: 22098185
    [Abstract] [Full Text] [Related]

  • 19. Retinal vein thrombosis associated with peginterferon alpha 2b plus ribavirin in a chronic hepatitis C patient.
    Such Díaz A, Barrueco N, Esteban Alba C, Escobar Rodríguez I.
    Farm Hosp; 2011 Jul 01; 35(2):93-4. PubMed ID: 20615736
    [No Abstract] [Full Text] [Related]

  • 20. Combination pegylated interferon and ribavirin therapy precipitating acute renal failure and exacerbating IgA nephropathy.
    Gordon A, Menahem S, Mitchell J, Jenkins P, Dowling J, Roberts SK.
    Nephrol Dial Transplant; 2004 Aug 01; 19(8):2155. PubMed ID: 15252182
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.